As we’ve spoken about in previous blog posts, the psychedelics industry has been rapidly expanding to become a key component in the treatment of a host of mental illnesses. With ...
Summary of our psychedelics podcast series: “Micro-dosing with Zeifmans”
Innovations in psychedelics are poised to disrupt the pharmaceutical industry, and the Zeifmans Cannabis and Psychedelics Team has been hard at work in the space and is here to demystify ...
Psychedelics investors are seeking 3 key qualities
Research is proving the impressive efficacy of psychedelics in treating conditions like anxiety, depression, and opioid addiction. Psychedelic substances like MDMA, LSD, ketamine, and most notably psilocybin (magic mushrooms) have ...